F. Hoffmann-La Roche is a manufacturer of pharmaceuticals and diagnostic devices.
The emergence of mandatory human rights and environmental due diligence is a pivotal moment for firms to demonstrate a commitment to good corporate governance.
Roche ‘Personalised Health Index’ enables Asia-Pacific stakeholders to use data to improve and personalize healthcare systems using the latest technology.
Businessman and philanthropist, André Hoffmann explores the ways COVID-19 will change our relationship to nature, and how it will make us more resilient.
